Preprint has been published in a journal as an article
DOI of the published article https://doi.org/10.1590/1677-5449.200057
Preprint / Version 1

Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

##article.authors##

  • Paulo Eduardo Ocke Reis Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil https://orcid.org/0000-0001-5450-6806
  • Marcos Cesar Braga Lima Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil

Keywords:

COVID-19, coronavirus, anticoagulants, thrombosis, prevention, hospital mortality

Abstract

Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.

Posted

2020-05-18

Section

Health Sciences